After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
A healthy pullback in Amgen would create a low-risk buying opportunity.
Amgen (AMGN) stock is up on Thursday afternoon following the company’s solid earnings and revenue results for the 2016 second quarter, and upbeat guidance.
Facebook (FB) smashed earnings expectations--again. Shares are hitting record highs in the pre-market.
Stocks remain very unconcerned about rates, despite the odds of a fall increase slightly rising.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.